Professor, Internal Medicine, Temple University School of Medicine
Gastroenterology
Dr. Henry Parkman, MD
|
|
Give Review
Henry Parkman, MD is an expert in the field of Gastroenterology. He researched medicine at Case Western Reserve University School of Medicine. He received awards:"Super Doctor" and "Fellow (FACG)". Henry Parkman is a published physician. He has 95 publications published. The most current publication "Emerging strategies for the treatment of gastroparesis." Doctor Henry Parkman, MD accepts all Medicare patients.
Publications
- Emerging strategies for the treatment of Gastroparesis.
- Drug-drug interactions in pharmacologic management of Gastroparesis.
- Current advances in treatment of Gastroparesis.
- Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with Gastroparesis.
- Effect of dietary fat and food consistency on Gastroparesis symptoms in patients with Gastroparesis.
- Improving our understanding of Gastroparesis.
- Gastroparesis: definitions and diagnosis.
- Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
- Association of low numbers of CD206-positive cells with loss of ICC in the Gastric body of patients with diabetic gastroparesis.
- Response to dr. Lankarani.
- Granisetron Transdermal System Improves Refractory Nausea and Vomiting in Gastroparesis.
- Small Intestinal bacterial overgrowth in gastroparesis.
- Bolus retention in Hiatal hernia identified by high-resolution esophageal manometry with impedance.
- Metoclopramide nasal spray is effective in symptoms of Gastroparesis in diabetics compared to conventional oral tablet.
- Effect of nortriptyline on symptoms of idiopathic Gastroparesis: the NORIG randomized clinical trial.
- Bodyweight in Patients with Idiopathic Gastroparesis: Roles of Symptoms, Caloric Intake, Physical Activity, and Body Metabolism.
- The SNMMI and EANM Practice Guideline for Small-Bowel and Colon Transit 1.0.
- Response to Arnold and beaves.
- Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis.
- Migraine and Gastroparesis from a gastroenterologist's perspective.
- Identification of domperidone metabolites in plasma and urine of Gastroparesis patients with LC-ESI-MS/MS.
- Use of a High Caloric Liquid Meal as an Alternative to a Solid Meal for Gastric Emptying Scintigraphy.
- Surgical outcomes after Gastric electric stimulator placement for refractory gastroparesis.
- Cholecystectomy and Clinical Presentations of Gastroparesis.
- Factors related to Abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.
- Clinical guideline: management of Gastroparesis.
- Slow esophageal propagation velocity: association with Dysphagia for solids.
- Use of the Montreal global definition as an assessment of quality of life in reflux Disease.
- Symptoms and Esophageal motility based on phenotypic findings of scleroderma.
- DNA microarray SNP associations with clinical efficacy and side effects of domperidone treatment for Gastroparesis.
- Chronic Idiopathic Constipation: More Than A Simple Colonic Transit Disorder.
- Gastric Emptying Scintigraphy: Is Four Hours Necessary?
- Similarities and differences between diabetic and idiopathic Gastroparesis.
- Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation.
- Continuous Glucose Monitoring in Gastroparesis.
- Altered expression of ano1 variants in human diabetic Gastroparesis.
- Bloating in Gastroparesis: Severity, Impact, and Associated Factors.
- Gastric emptying of solids and liquids for evaluation for gastroparesis.
- Characteristics of nausea and its effects on quality of life in diabetic and idiopathic Gastroparesis.
- Characteristics of Patients With Chronic Unexplained Nausea and Vomiting and Normal Gastric Emptying.
- Domperidone treatment for Gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.
- Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study.
- Identification of novel metoclopramide metabolites in humans: in vitro and in vivo studies.
- Abdominal pain is a frequent symptom of gastroparesis.
- Treatment of patients with diabetic Gastroparesis.
- Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values.
- Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls.
- Effect of atilmotin, a motilin receptor agonist, on Esophageal, lower Esophageal sphincter, and gastric pressures.
- Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies.
- Heightened colon motor activity measured by a wireless capsule in patients with Constipation: relation to colon transit and IBS.
- Factors contributing to hospitalization for Gastroparesis exacerbations.
- Wireless capsule motility: comparison of the SmartPill GI monitoring System with scintigraphy for measuring whole gut transit.
- Tests of Gastric neuromuscular function.
- Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in Constipation.
- Investigation of Colonic and Whole Gut Transit with Wireless Motility Capsule and Radioopaque Markers in Constipation.
- The Gastrointestinal motility laboratory.
- Assessment of gastric emptying and small-bowel Motility: scintigraphy, breath tests, manometry, and SmartPill.
- Persistent nausea and Abdominal pain in a patient with delayed gastric emptying.
- Predictive factors for clinical improvement with Enterra Gastric electric stimulation treatment for refractory gastroparesis.
- Transsphincteric pH profile at the gastroEsophageal junction.
- Differences in intraGastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of Gastric retention.
- Egg Labeling for Gastric-Emptying Studies.
- Tonic and phasic pyloric activity in response to CCK-octapeptide.
- Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004.
- Botulinum toxin A for the treatment of delayed Gastric emptying.
- Egg labeling methods for Gastric emptying scintigraphy are not equivalent in producing a stable solid meal.
- Advances in the management of Gastroparesis.
- Gastric electric stimulation for the treatment of gastroparesis.
- Abnormal ghrelin and pancreatic polypeptide responses in Gastroparesis.
- Delayed Gastric emptying: whom to test, how to test, and what to do.
- Update on Gastrointestinal scintigraphy.
- Regional postprandial differences in pH within the stomach and gastroesophageal junction.
- Increased Barrett's Esophagus for the decade between 1991 and 2000 at a single university medical center.
- Management of delayed Gastric emptying.
- Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory Gastroparesis.
- Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in Esophageal carcinoma.
- Chronic Intestinal Pseudo-Obstruction.
- Achalasia presenting after operative and nonoperative trauma.
- Regional gastric conTractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation.
- Simultaneous assessment of Gastric accommodation and emptying: studies with liquid and solid meals.
- Multichannel electrogastrography (EGG) in normal subjects: a multicenter study.
- Multichannel electrogastrography (EGG) in symptomatic patients: a single center study.
- The use of botulinum toxin for the treatment of Gastrointestinal motility disorders.
- Esophageal bacteria and Barrett's Esophagus: a preliminary report.
- Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal Esophagus, oropharynx, and lung.
- Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle.
- Effect of altering Gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.
- Treatment of idiopathic Gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
- Treatment of chest Pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophage...
- Simultaneous measurement of Gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic...
- Barrett's esophagus and Achalasia.
- Functional (NonUlcer) Dyspepsia.
- New advances in the diagnosis and management of nausea and vomiting.
- Gastroparesis after combined heart and lung transplantation.
Schools
Case Western Reserve University School of Medicine
Johns Hopkins Hospital
Hospital Of The University Of Pennsylvania
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Achalasia
- Anemia
- Autonomic Dysfunction on the GastroIntestinal Tract
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Super Doctor
- Fellow (FACG)
Education
-
University of Pennsylvania Health System -
Johns Hopkins University -
Case Western Reserve University School of Medicine
Hospital
-
Temple University Hospital
Drug Facts
| NPI NUMBER | 1770501975 | |
| NPPES Provider LastName | PARKMAN | |
| NPPES Provider FirstName | HENRY | |
| NPPES Provider ZIPCode | 191405103 | |
| NPPES Provider State | PA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1244.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 83.0 | |
| Percent Opioid Claims | 6.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770501975 |
| Last Name Of The Provider | PARKMAN |
| First Name Of The Provider | HENRY |
| View All |
Similar Doctors
|
Dr. Rotonya L. McCants Carr, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali A. Siddiqui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra N. Modiri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina J. Tofani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina A. Twyman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher H. Henry, MD |
|
|
Dr. Paul L. Berenbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel M. Quirk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason A. Korenblit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco L. Toledo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leyla J. Ghazi, MD |
|
|
Dr. Michael J. Rosner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael C. Dimarino, MD
This Doctor is OpenDoctor Recommended.
|